
79
Cooper, A. J., Sheu, K. F., Burke, J. R., Onodera, O., Strittmatter, W. J., Roses, A. D., Blass, J. P. (1997).
"Polyglutamine domains are substrates of tissue transglutaminase: does transglutaminase play a role in expanded
CAG/poly-Q neurodegenerative diseases?" J Neurochem
69(1): 431-4.
De Rycke, J., Gonzalez, E. A., Blanco, J., Oswald, E., Blanco, M., Boivin, R. (1990). "Evidence for two types
of cytotoxic necrotizing factor in human and animal clinical isolates of Escherichia coli." J Clin Microbiol
28(4):
694-9.
Diekmann, D., Abo, A., Johnston, C., Segal, A. W., Hall, A. (1994). "Interaction of Rac with p67phox and
regulation of phagocytic NADPH oxidase activity." Science
265(5171): 531-3.
Edwards, D. C., Sanders, L. C., Bokoch, G. M., Gill, G. N. (1999). "Activation of LIM-kinase by Pak1
couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics." Nat Cell Biol
1(5): 253-9.
Ellis, R. W., Defeo, D., Shih, T. Y., Gonda, M. A., Young, H. A., Tsuchida, N., Lowy, D. R., Scolnick, E. M.
(1981). "The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family
of normal vertebrate genes." Nature
292(5823): 506-11.
Fabbri, A., Gauthier, M., Boquet, P. (1999). "The 5' region of cnf1 harbours a translational regulatory
mechanism for CNF1 synthesis and encodes the cell-binding domain of the toxin." Mol Microbiol
33(1): 108-18.
Falbo, V., Pace, T., Picci, L., Pizzi, E., Caprioli, A. (1993). "Isolation and nucleotide sequence of the gene
encoding cytotoxic necrotizing factor 1 of Escherichia coli." Infect Immun
61(11): 4909-14.
Fesus, L. and Z. Szondy (2005). "Transglutaminase 2 in the balance of cell death and survival." FEBS Lett
579(15): 3297-302.
Fiorentini, C., Arancia, G., Caprioli, A., Falbo, V., Ruggeri, F. M., Donelli, G. (1988). "Cytoskeletal changes
induced in HEp-2 cells by the cytotoxic necrotizing factor of Escherichia coli." Toxicon
26(11): 1047-56.
Flatau, G., Landraud, L., Boquet, P., Bruzzone, M., Munro, P. (2000). "Deamidation of RhoA glutamine 63
by the Escherichia coli CNF1 toxin requires a short sequence of the GTPase switch 2 domain." Biochem
Biophys Res Commun 267(2): 588-92.
Flatau, G., Lemichez, E., Gauthier, M., Chardin, P., Paris, S., Fiorentini, C., Boquet, P. (1997). "Toxin-
induced activation of the G protein p21 Rho by deamidation of glutamine." Nature
387(6634): 729-33.
Forth, W., Aktories, K. (2005). Allgemeine und spezielle Pharmakologie und Toxikologie
., 9. Aufl., Urban und
Fischer, München, Jena.
Foster, R., Hu, K. Q., Lu, Y., Nolan, K. M., Thissen, J., Settleman, J. (1996). "Identification of a novel
human Rho protein with unusual properties: GTPase deficiency and in vivo farnesylation." Mol Cell Biol
16(6):
2689-99.
Fransson, A., Ruusala, A., Aspenstrom, P. (2003). "Atypical Rho GTPases have roles in mitochondrial
homeostasis and apoptosis." J Biol Chem
278(8): 6495-502.
Frost, J. A., Xu, S., Hutchison, M. R., Marcus, S., Cobb, M. H. (1996). "Actions of Rho family small G
proteins and p21-activated protein kinases on mitogen-activated protein kinase family members." Mol Cell Biol
16(7): 3707-13.
Garavini, H., Riento, K., Phelan, J. P., McAlister, M. S., Ridley, A. J., Keep, N. H. (2002). "Crystal structure
of the core domain of RhoE/Rnd3: a constitutively activated small G protein." Biochemistry
41(20): 6303-10.
Gasman, S., Kalaidzidis, Y., Zerial, M. (2003). "RhoD regulates endosome dynamics through Diaphanous-
related Formin and Src tyrosine kinase." Nat Cell Biol
5(3): 195-204.
Gjoerup, O., Lukas, J., Bartek, J., Willumsen, B. M. (1998). "Rac and Cdc42 are potent stimulators of E2F-
dependent transcription capable of promoting retinoblastoma susceptibility gene product hyperphosphorylation."
J Biol Chem 273(30): 18812-8.
Comentarios a estos manuales